bulk ghk-cu – Research Peptide GHK-Cu 50mg Copper Peptide Research-Grade

Medical Device Application Technical Files such as device description, intended purpose, design and manufacturing details, labeling, risk assessment, and clinical evidence (if required) Australian Declaration of Conformity Manufacturers Evidence (CE Certificate) Appointment of Australian Sponsor Pre-Market Evaluation For higher-risk device classes such as Class IIb and III, a pre-market evaluation may be required

GHK-Cu is a copper-complexed tripeptide (Glycine-Histidine-Lysine-Cu) naturally present in human plasma, saliva, and urine

Beginner Protocol (Weeks 1-2) For individuals new to 5-amino-1MQ peptide therapy, a conservative starting dose of 50mg daily is recommended

Siga corretamente o modo de uso

Regular assessments help tailor therapy to each patients needs.

Our catalog includes GLP-related compounds, peptide blends, and individual research peptides commonly used in metabolic, signaling, and structural studies